Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proton International Arkansas is the operating entity behind the Proton Center of Arkansas in Little Rock, a commercial proton beam radiation therapy center that treats cancer patients. The company is a joint venture involving UAMS, Arkansas Children's, Baptist Health, and a Proton International affiliate, and it operates Arkansas' first proton therapy facility. Its business is healthcare delivery rather than drug development, centered on delivering proton radiation for pediatric and adult oncology indications. The center uses IBA's ProteusONE system with pencil beam scanning and related image-guided treatment capabilities. Although the center remains open and active, public reports in 2025 and 2026 indicate financial covenant and bond-default stress tied to patient volumes and cash reserves.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proton International Arkansas.